1. Home
  2. DINO vs RGEN Comparison

DINO vs RGEN Comparison

Compare DINO & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo HF Sinclair Corporation

DINO

HF Sinclair Corporation

HOLD

Current Price

$113.63

Market Cap

12.9B

Sector

Energy

ML Signal

HOLD

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$185.07

Market Cap

11.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DINO
RGEN
Founded
1947
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Medical/Dental Instruments
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.9B
11.0B
IPO Year
2022
1995

Fundamental Metrics

Financial Performance
Metric
DINO
RGEN
Price
$113.63
$185.07
Analyst Decision
Hold
Buy
Analyst Count
17
21
Target Price
$123.94
★ $200.56
AVG Volume (30 Days)
★ 2.0M
1.2M
Earning Date
10-28-2026
10-27-2026
Dividend Yield
★ 1.84%
N/A
EPS Growth
238.46
★ 286.96
EPS
★ 8.48
0.24
Revenue
N/A
★ $141,236,000.00
Revenue This Year
$31.33
$14.96
Revenue Next Year
N/A
$26.06
P/E Ratio
★ $13.47
$724.65
Revenue Growth
N/A
★ 35.10
52 Week Low
$45.71
$100.99
52 Week High
$129.37
$198.87

Technical Indicators

Market Signals
Indicator
DINO
RGEN
Relative Strength Index (RSI) 43.24 56.01
Support Level $103.00 $159.29
Resistance Level $118.39 $187.36
Average True Range (ATR) 5.26 8.54
MACD -1.68 0.21
Stochastic Oscillator 20.30 94.77

Price Performance

Historical Comparison
DINO
RGEN

About DINO HF Sinclair Corporation

HF Sinclair is an integrated petroleum refiner that owns and operates seven refineries serving the Rockies, midcontinent, Southwest, and Pacific Northwest, with a total crude oil throughput capacity of 678,000 barrels per day. It can produce 380 million gallons of renewable diesel annually. It holds a marketing business with over 350 distributors and 1,700 wholesale branded sites across 30 states. It also owns and operates 4,500 miles of petroleum product pipelines and terminals principally in the southwestern United States.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, and other life science companies. It sells four main product categories: filtration and fluid management is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia-Pacific contribute about 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: